These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16269054)

  • 1. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukaemia.
    Faraci M; Micalizzi C; Lanino E; Scuderi F; Morreale G; Dini G; Cappelli B; Dallorso S
    Pediatr Transplant; 2005 Dec; 9(6):797-800. PubMed ID: 16269054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature.
    Matthes-Martin S; Mann G; Peters C; Lion T; Fritsch G; Haas OA; Pötschger U; Gadner H
    Bone Marrow Transplant; 2000 Aug; 26(4):377-82. PubMed ID: 10982283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML.
    Pulsipher MA; Adams RH; Asch J; Petersen FB
    Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
    Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
    Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
    Yoshimi A; Niemeyer CM; Bohmer V; Duffner U; Strahm B; Kreyenberg H; Dilloo D; Zintl F; Claviez A; Wössmann W; Kremens B; Holter W; Niethammer D; Beck JF; Kontny U; Nöllke P; Klingebiel T; Bader P
    Br J Haematol; 2005 May; 129(4):542-9. PubMed ID: 15877738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review.
    Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):190-3. PubMed ID: 15125612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia.
    Orchard PJ; Miller JS; McGlennen R; Davies SM; Ramsay NK
    Bone Marrow Transplant; 1998 Jul; 22(2):201-3. PubMed ID: 9707031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K; Groll AH; Kuehn J; Vormoor J
    Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.
    Jakovljević G; Kardum-Skelin I; Rogosić S; Nakić M
    Coll Antropol; 2010 Mar; 34(1):251-4. PubMed ID: 20432758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.
    Ohta H; Kawai M; Sawada A; Tokimasa S; Fujisaki H; Matsuda Y; Osugi Y; Okada S; Hara J
    Bone Marrow Transplant; 2000 Sep; 26(6):681-3. PubMed ID: 11041570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
    Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
    Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML).
    Neudorf S; Nourani A; Kempert P; Shen V; Sender L; Kirov I
    Bone Marrow Transplant; 2004 May; 33(10):1069. PubMed ID: 15064688
    [No Abstract]   [Full Text] [Related]  

  • 17. A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Yabe M; Sako M; Yabe H; Osugi Y; Kurosawa H; Nara T; Tokuyama M; Adachi S; Kobayashi C; Yanagimachi M; Ohtsuka Y; Nakazawa Y; Ogawa C; Manabe A; Kojima S; Nakahata T;
    Pediatr Transplant; 2008 Dec; 12(8):862-7. PubMed ID: 18397212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
    Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
    Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.